Leila Colgan

Leila Colgan

Corporate Officer/Principal bij Healthcare Businesswomens Association

Health Technology
Health Services
Commercial Services

Profiel

Leila Colgan is a professional who has worked in various pharmaceutical and healthcare companies.
She is currently a member of the Healthcare Businesswomens Association.
Previously, she worked as a Certified Neuroscience Specialist at Abbott Laboratories, a Sales Specialist at Agouron Pharmaceuticals LLC, a Senior Biopharmaceutical Representative at Amgen, Inc., a Market Development Specialist at Merck & Co., Inc., a Manager-Solid Tumor Marketing at Clarient, Inc., a Vice President-Sales & Marketing at MYnd Analytics, Inc., a Vice President-Sales & Marketing at LungLife AI, Inc., and a Pharmaceutical Specialist at AstraZeneca Pharmaceuticals LP.
She received her undergraduate degree and MBA from Pepperdine University.

Actieve functies van Leila Colgan

BedrijvenFunctieBegin
Corporate Officer/Principal -
Alle actieve functies van Leila Colgan

Eerdere bekende functies van Leila Colgan

BedrijvenFunctieEinde
Verkoop & Marketing -
MERCK & CO., INC. Corporate Officer/Principal -
ABBOTT LABORATORIES Corporate Officer/Principal -
Corporate Officer/Principal -
Verkoop & Marketing -
Ervaring van Leila Colgan in detail bekijken

Opleiding van Leila Colgan

Pepperdine University Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Leila Colgan in detail bekijken

Connecties

55

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
LUNGLIFE AI, INC.

Health Services

AMGEN INC.

Health Technology

MERCK & CO., INC.

Health Technology

ABBOTT LABORATORIES

Health Technology

Bedrijven in privébezit5

Commercial Services

Health Services

Health Technology

Health Technology

Health Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Leila Colgan
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU